USADA announced today that, Tara Harbert, of Longmont, Colorado, an athlete in the sport of baseball, has received an eight year suspension for her first and second anti-doping rule violations. Harbert, 33, tested positive for Tamoxifen and its metabolites, 3-hydroxy-4-methoxytamoxifen, 4-hydroxytamoxifen and N-desmethyltamoxifen, in out-of-competition samples collected on June 23, 2015 and July 6, 2015.

Tamoxifen is a prohibited substance in the class of Hormone Antagonists and Modulators. Harbert also failed to submit to sample collection without compelling justification on August 22, 2015. The finding of a prohibited substance in an athlete’s sample as well as the failure to submit to sample collection with compelling justification are independent anti-doping rule violations and are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the rules of the World Baseball Softball Confederation (WBSC), both of which adopt the World Anti-Doping Code.

Harbert’s eight-year sanction began on July 7, 2015, the day she received notice of a provisional suspension for her first positive test. As a result of the sanction, Harbert is disqualified from all competitive results obtained on and subsequent to June 23, 2015, the date of her first positive test, including forfeiture of any medals, points, and prizes.

• This media release was originally published on the US Anti-Doping Agency’s (USADA) internet site on 21 December 2015. To access the original, please click here.